Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

EDWARD MARION TAVEL

Allopathic & Osteopathic Physicians Pain Medicine Pain Medicine

NPI
1508833468
CMS profile
295429
Location
CHARLESTON, SC

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$225.10

4 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $225.10 4

By paying entity

PY2024 · entire year · sorted by reported total

Paying entityAmountRecords
Abbott Laboratories $180.47 3
SI-BONE, INC. $44.63 1

Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

EDWARD MARION TAVEL

NPI 1508833468 · CMS profile ID 295429

Allopathic & Osteopathic Physicians / Pain Medicine / Pain Medicine

CHARLESTON, SC

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1508833468?year=2024&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
EDWARD MARION TAVEL, NPI 1508833468, CMS profile ID 295429. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1508833468?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). EDWARD MARION TAVEL, NPI 1508833468, CMS profile ID 295429. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1508833468?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
EDWARD MARION TAVEL, NPI 1508833468, CMS profile ID 295429, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–4 of 4 matching records. This page contains 4 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1508833468?year=2024&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

4 matching records · $225.10 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 4 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–4 of 4.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Abbott Laboratories $11.5109/05/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1125101354 CMS
Abbott Laboratories $10.3006/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1125101352 CMS
SI-BONE, INC. $44.6304/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1120060535 CMS
Abbott Laboratories $158.6603/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1125101350 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $298.90 19
PY2020 $211.18 10
PY2021 $196.58 12
PY2022 $145.16 4
PY2023 $152.15 3
PY2024 $225.10 4
PY2025 $1,202.06 20

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $76,931.00 6
PY2024 Principal investigator $5,493.00 5
PY2023 Principal investigator $36,326.87 10
PY2022 Principal investigator $206,426.48 18
PY2021 Principal investigator $480,791.84 39
PY2020 Principal investigator $359,176.17 70
PY2019 Principal investigator $217,263.17 23

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

39 records in PY2021

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Abbott Laboratories $135.00 10/14/2021 Non-covered Recipient Entity
Western Institutional Review Board, Inc. (WIRB)
DISTINCT No dispute reported 06/30/2026 827560521
Principal investigator 1 Abbott Laboratories $11,914.00 10/06/2021 Non-covered Recipient Entity
CLINICAL TRIALS OF SOUTH CAROLINA
DISTINCT No dispute reported 06/30/2026 827567283
Principal investigator 1 Abbott Laboratories $16,678.67 09/15/2021 Non-covered Recipient Entity
CLINICAL TRIALS OF SOUTH CAROLINA
DISTINCT No dispute reported 06/30/2026 827567277
Principal investigator 1 Abbott Laboratories $49,851.64 09/15/2021 Non-covered Recipient Entity
CLINICAL TRIALS OF SOUTH CAROLINA
DISTINCT No dispute reported 06/30/2026 827567279
Principal investigator 1 Abbott Laboratories $8,247.15 09/15/2021 Non-covered Recipient Entity
CLINICAL TRIALS OF SOUTH CAROLINA
DISTINCT No dispute reported 06/30/2026 827567281
Principal investigator 1 IRONWOOD PHARMACEUTICALS, INC $1,019.85 09/15/2021 Non-covered Recipient Entity
CLINICAL TRIALS OF SOUTH CAROLINA - CLINEDGE - PPDS
C3718-302 No dispute reported 06/30/2026 831598197
Principal investigator 1 IRONWOOD PHARMACEUTICALS, INC $44,169.28 09/15/2021 Non-covered Recipient Entity
CLINICAL TRIALS OF SOUTH CAROLINA - CLINEDGE - PPDS
C3718-302 No dispute reported 06/30/2026 831599505
Principal investigator 1 Abbott Laboratories $135.00 09/09/2021 Non-covered Recipient Entity
Western Institutional Review Board, Inc. (WIRB)
DISTINCT No dispute reported 06/30/2026 827560519
Principal investigator 1 Abbott Laboratories $1,250.00 09/02/2021 Non-covered Recipient Entity
Western Institutional Review Board, Inc. (WIRB)
DISTINCT No dispute reported 06/30/2026 827560517
Principal investigator 1 Abbott Laboratories $12,460.00 08/11/2021 Non-covered Recipient Entity
CLINICAL TRIALS OF SOUTH CAROLINA
DISTINCT No dispute reported 06/30/2026 827567263
Principal investigator 1 IRONWOOD PHARMACEUTICALS, INC $1,080.00 08/04/2021 Non-covered Recipient Entity
CLINICAL TRIALS OF SOUTH CAROLINA - CLINEDGE - PPDS
C3718-302 No dispute reported 06/30/2026 831598207
Principal investigator 1 IRONWOOD PHARMACEUTICALS, INC $810.00 07/23/2021 Non-covered Recipient Entity
CLINICAL TRIALS OF SOUTH CAROLINA - CLINEDGE - PPDS
C3718-302 No dispute reported 06/30/2026 831596839
Principal investigator 1 Abbott Laboratories $4,765.00 07/21/2021 Non-covered Recipient Entity
Spinal Consultants Todd Lansford, MD
DISTINCT No dispute reported 06/30/2026 827567261
Principal investigator 1 Abbott Laboratories $135.00 07/01/2021 Non-covered Recipient Entity
Western Institutional Review Board, Inc. (WIRB)
DISTINCT No dispute reported 06/30/2026 827560509
Principal investigator 1 Abbott Laboratories $33,172.97 06/30/2021 Non-covered Recipient Entity
CLINICAL TRIALS OF SOUTH CAROLINA
DISTINCT No dispute reported 06/30/2026 827567273
Principal investigator 1 Abbott Laboratories $24,925.82 06/30/2021 Non-covered Recipient Entity
CLINICAL TRIALS OF SOUTH CAROLINA
DISTINCT No dispute reported 06/30/2026 827567275
Principal investigator 1 Abbott Laboratories $280.00 06/03/2021 Non-covered Recipient Entity
Western Institutional Review Board, Inc. (WIRB)
A Post-Market Study Evaluating the Prodigy MRI and Proclaim Elite MR Conditional SCS Systems No dispute reported 06/30/2026 827558843
Principal investigator 1 Abbott Laboratories $335.00 06/03/2021 Non-covered Recipient Entity
Western Institutional Review Board, Inc. (WIRB)
A Post-Market Study Evaluating the Prodigy MRI and Proclaim Elite MR Conditional SCS Systems No dispute reported 06/30/2026 827558845
Principal investigator 1 Abbott Laboratories $135.00 05/27/2021 Non-covered Recipient Entity
Western Institutional Review Board, Inc. (WIRB)
DISTINCT No dispute reported 06/30/2026 827560513
Principal investigator 1 Abbott Laboratories $280.00 05/27/2021 Non-covered Recipient Entity
Western Institutional Review Board, Inc. (WIRB)
MulTi-center pRospectIve stUdy deterMining the sustainability of Pain relief and psychosocial and functional responses wHen utilizing a multiple waveform enabled neurostimulator No dispute reported 06/30/2026 827561545
Principal investigator 1 Abbott Laboratories $49,851.64 05/19/2021 Non-covered Recipient Entity
CLINICAL TRIALS OF SOUTH CAROLINA
DISTINCT No dispute reported 06/30/2026 827567271
Principal investigator 1 Abbott Laboratories $135.00 05/13/2021 Non-covered Recipient Entity
Western Institutional Review Board, Inc. (WIRB)
DISTINCT No dispute reported 06/30/2026 827560511
Principal investigator 1 Abbott Laboratories $11,460.00 05/05/2021 Non-covered Recipient Entity
CLINICAL TRIALS OF SOUTH CAROLINA
DISTINCT No dispute reported 06/30/2026 827567269
Principal investigator 1 Abbott Laboratories $135.00 04/30/2021 Non-covered Recipient Entity
Western Institutional Review Board, Inc. (WIRB)
DISTINCT No dispute reported 06/30/2026 827560515
Principal investigator 1 SEIKAGAKU CORPORATION $6,729.00 04/14/2021 Non-covered Recipient Entity
Clinical Trials of South Carolina
6603/1133 No dispute reported 06/30/2026 807677981
Principal investigator 1 Abbott Laboratories $3,812.00 03/31/2021 Non-covered Recipient Entity
Spinal Consultants Todd Lansford, MD
DISTINCT No dispute reported 06/30/2026 827567265
Principal investigator 1 Abbott Laboratories $174,112.00 03/31/2021 Non-covered Recipient Entity
CLINICAL TRIALS OF SOUTH CAROLINA
DISTINCT No dispute reported 06/30/2026 827567267
Principal investigator 1 SEIKAGAKU CORPORATION $5,628.00 03/17/2021 Non-covered Recipient Entity
Clinical Trials of South Carolina
6603/1133 No dispute reported 06/30/2026 807677979
Principal investigator 1 Abbott Laboratories $1,355.00 02/10/2021 Non-covered Recipient Entity
CLINICAL TRIALS OF SOUTH CAROLINA
A Post-Market Study Evaluating the Prodigy MRI and Proclaim Elite MR Conditional SCS Systems No dispute reported 06/30/2026 827567257
Principal investigator 1 Abbott Laboratories $1,264.00 02/05/2021 Non-covered Recipient Entity
Western Institutional Review Board, Inc. (WIRB)
A Post-Market Study Evaluating the Prodigy MRI and Proclaim Elite MR Conditional SCS Systems No dispute reported 06/30/2026 827558841
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $698.32 02/04/2021 Non-covered Recipient Entity
CLINICAL TRIALS OF SOUTH CAROLINA
A RANDOMIZED, DOUBLE-BLIND, MULTI-DOSE, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF REGN5069 IN PATIENTS WITH PAIN DUE TO OSTEOARTHRITIS OF THE KNEE No dispute reported 06/30/2026 793093987
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $600.00 02/04/2021 Non-covered Recipient Entity
CLINICAL TRIALS OF SOUTH CAROLINA
A RANDOMIZED, DOUBLE-BLIND, MULTI-DOSE, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF REGN5069 IN PATIENTS WITH PAIN DUE TO OSTEOARTHRITIS OF THE KNEE No dispute reported 06/30/2026 793093989
Principal investigator 1 Abbott Laboratories $9,092.00 02/03/2021 Non-covered Recipient Entity
CLINICAL TRIALS OF SOUTH CAROLINA
DISTINCT No dispute reported 06/30/2026 827567259
Principal investigator 1 Allergan, Inc. $141.50 01/26/2021 Non-covered Recipient Entity
CLINICAL TRIALS OF SOUTH CAROLINA LLC ATTN:
46 weeks, placebo controlled (pts from 01/02 studies roll over for 53 weeks total exposure) No dispute reported 06/30/2026 789000833
Principal investigator 1 Abbott Laboratories $455.00 01/22/2021 Non-covered Recipient Entity
Western Institutional Review Board, Inc. (WIRB)
DISTINCT No dispute reported 06/30/2026 827560507
Principal investigator 1 Allergan, Inc. $376.75 01/19/2021 Non-covered Recipient Entity
CLINICAL TRIALS OF SOUTH CAROLINA LLC ATTN:
A 12-week, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Safety and Efficacy of Relamorelin in Patients with Diabetic Gastroparesis No dispute reported 06/30/2026 789000831
Principal investigator 1 Allergan, Inc. $2,947.50 01/18/2021 Non-covered Recipient Entity
CLINICAL TRIALS OF SOUTH CAROLINA LLC ATTN:
A 12-week, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Safety and Efficacy of Relamorelin in Patients with Diabetic Gastroparesis No dispute reported 06/30/2026 789000829
Principal investigator 1 Abbott Laboratories $130.00 01/15/2021 Non-covered Recipient Entity
Western Institutional Review Board, Inc. (WIRB)
DISTINCT No dispute reported 06/30/2026 827560505
Principal investigator 1 Allergan, Inc. $89.75 01/14/2021 Non-covered Recipient Entity
CLINICAL TRIALS OF SOUTH CAROLINA LLC ATTN:
A 52-week, double blind, Phase 3 Study for Assessment of the Safety and Effectiveness of Relamorelin in Patients with Diabetic Gastroparesis No dispute reported 06/30/2026 789000827